Dr. Michael Har-Noy Indicates That We Are Losing The War Against Cancer - PowerPoint PPT Presentation

About This Presentation
Title:

Dr. Michael Har-Noy Indicates That We Are Losing The War Against Cancer

Description:

Dr. Michael Har-Noy founder and CEO of Immunovative Therapies, Ltd., is devising unique methods cancer therapy. Dr. Michael Har-Noy has spent his career formulating immunologic drugs that may benefit millions of victims of cancer. Three of Dr. Michael Har-Noy’s prototype drugs, AlloStimTM, CryoStimTM, and AlloVaxTM, have the potential to completely eliminate different types of cancer cells at any stage of growth. These unique drugs may truly revolutionize the way oncology is practiced. – PowerPoint PPT presentation

Number of Views:26
Slides: 6
Provided by: michaelharnoy

less

Transcript and Presenter's Notes

Title: Dr. Michael Har-Noy Indicates That We Are Losing The War Against Cancer


1
Dr. Michael Har-Noy Indicates That We Are Losing
The War Against Cancer
We are losing the fight against cancer says Dr.
Michael Har-Noy, CEO of Immunovative Therapies, a
young biotech firm started in Israel in 2004.
Dr. Michael Har-Noy indicates that in past 30
years, the incidence of cancer has increased
dramatically, affecting almost one out of every
three females and one out of every two males..
This means that the current rate of cancer is 50
higher in men and 25 higher in women than in the
past generation. The National Cancer Institute
predicts that, because of our growing elderly
population, the number of cancer cases will
virtually double by the year 2050.
2
Develops Cutting Edge Cancer Treatments
Dr. Michael Har-Noy, founder and CEO of
Immunovative Therapies, Ltd., says that
developing and marketing new drugs can be an
arduous task. The many regulations that exist in
most countries cost much time and money comply
with. Small companies often dont survive the
startup phase because they become cash-depleted
they are able to market any new products. These
unique drugs being created by Dr. Michael Har-Noy
appear far more effective than traditional cancer
treatments. They may create an entire new
industry in the treatment of cancer.
3
Dr. Michael Har-Noys Unique Anti-tumor Technology
Cancer is a horribly debilitating condition that
affects many million people worldwide says Dr.
Michael Har-Noy, founder of Immunovative
Therapies Ltd. About 40 of the population will
get sometime in their life. There are over one
million new cancer diagnoses each year. The
crippling effects of cancer work their way into
every part of a patients life, as well as those
of their loved
ones. Cancer is so hard to treat because it
usually produces no symptoms until it is very
advanced, and when it is discovered it has
usually progressed beyond the point where it can
be cured using conventional means.
Dr. Michael Har-Noy founded Immunovative
Therapies, Ltd., in 2004 in Israel. The company
grew out of the Misgav Venture Accelerator in
Israel and was given a 300,000 grant by the
Office of the Chief Scientist. Dr. Michael
Har-Noy and his staff are designing unique immune
treatments.
4
Develops Unique Cancer Drugs
Dr. Michael Har-Noy, of Immunovative Therapies,
Ltd., details their primary drug, AlloStimTM, as
a compound synthesized from cells from a normal
donor.  These cells are then purified,
differentiated, grown, and then stored until
used.  When given to a cancer patient, these
AlloStimTM creates an inflammatory environment
which disables a tumors avoidance capability. 
Dr. Michael Har-Noy notes that because AlloStimTM
cells are intentionally mismatched and are
detected as foreign by the host, the patients
immune response wakes up to these signals and
rejects both the AlloStimTM and the malignant
cells
5
http//michaelhar-noy.tumblr.com/
Write a Comment
User Comments (0)
About PowerShow.com